Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 4 6Phase 3 4Phase NA 2Phase 1 2

Status

Completed 56Active not recruiting 18Recruiting 17Terminated 13Withdrawn 9Unknown 8Not yet recruiting 1

Sponsor Class

OTHER 7OTHER_GOV 1

Study Type

Interventional 8

Sponsor

Cancer Type

Genitourinary 5Breast 3

Conditions

Prostatic Neoplasms 5Breast Neoplasms 3

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Leuprolide × Clear all
NCT03899077 2024-02-07

SAVE

Cancer Research Antwerp

Phase 2 Unknown
202 enrolled
Genitourinary

Prostatic Neoplasms

NCT05212857 2022-03-16

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Fudan University

Phase 2 Unknown
160 enrolled
Genitourinary

Prostatic Neoplasms

NCT03541928 2021-04-06

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

The Methodist Hospital Research Institute

Phase 2 Unknown
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT02742675 2020-07-07

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Fudan University

Phase 2 Unknown
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT02592746 2019-04-08

A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC

Samsung Medical Center

Phase 2 Unknown
182 enrolled
Breast

Breast Neoplasms

NCT02689921 2018-09-28

NEOADAPT

Midwestern Regional Medical Center

Phase 2 Unknown
7 enrolled
Breast

Breast Neoplasms

NCT03497702 2018-04-13

NeoChAI

National Cancer Center, Korea

Phase 2 Unknown
114 enrolled
Breast

Breast Neoplasms

NCT00452556 2014-03-19

The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study

Nova Scotia Cancer Centre

Phase 2 Unknown
86 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡